These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15592497)

  • 1. Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.
    Krasnoselsky AL; Whiteford CC; Wei JS; Bilke S; Westermann F; Chen QR; Khan J
    Oncogene; 2005 Feb; 24(9):1533-41. PubMed ID: 15592497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
    Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M
    Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
    Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
    Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
    Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
    Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.
    de Ruijter AJ; Meinsma RJ; Bosma P; Kemp S; Caron HN; van Kuilenburg AB
    Exp Cell Res; 2005 Oct; 309(2):451-67. PubMed ID: 16084510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
    Oberthuer A; Skowron M; Spitz R; Kahlert Y; Westermann F; Mehler K; Berthold F; Fischer M
    Gene; 2005 Dec; 363():41-50. PubMed ID: 16216448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; London W; Cohn SL; Brodeur GM; Ikegaki N
    Clin Cancer Res; 1999 Jun; 5(6):1491-6. PubMed ID: 10389937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
    J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturational sequence of neuroblastoma revealed by molecular analysis on cDNA microarrays.
    Yamanaka Y; Hamazaki Y; Sato Y; Ito K; Watanabe K; Heike T; Nakahata T; Nakamura Y
    Int J Oncol; 2002 Oct; 21(4):803-7. PubMed ID: 12239619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
    Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
    Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
    Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
    Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
    Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.
    Coco S; Theissen J; Scaruffi P; Stigliani S; Moretti S; Oberthuer A; Valdora F; Fischer M; Gallo F; Hero B; Bonassi S; Berthold F; Tonini GP
    Int J Cancer; 2012 Oct; 131(7):1591-600. PubMed ID: 22234802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas.
    Tang XX; Evans AE; Zhao H; Cnaan A; Brodeur GM; Ikegaki N
    Med Pediatr Oncol; 2001 Jan; 36(1):80-2. PubMed ID: 11464911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
    Fransson S; Martinsson T; Ejeskär K
    Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.